Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2015, Article ID 720198, 9 pages
http://dx.doi.org/10.1155/2015/720198
Research Article

Gold Nanoparticles Increase PLK1-Specific Small Interfering RNA Transfection and Induce Apoptosis of Drug Resistance Breast Cancer Cells

1Department of Medical Imaging, Jinling Hospital, School of Medicine, Nanjing University, Nanjing 210002, China
2State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210093, China

Received 22 May 2015; Accepted 27 July 2015

Academic Editor: Anh-Tuan Le

Copyright © 2015 Ying Tian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, J. Ma, Z. Zou, and A. Jemal, “Cancer statistics, 2014,” CA: A Cancer Journal for Clinicians, vol. 64, no. 1, pp. 9–29, 2014. View at Publisher · View at Google Scholar
  2. L. Fan, K. Strasser-Weippl, J.-J. Li et al., “Breast cancer in China,” The Lancet Oncology, vol. 15, no. 7, pp. e279–e289, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Schroeder, D. A. Heller, M. M. Winslow et al., “Treating metastatic cancer with nanotechnology,” Nature Reviews Cancer, vol. 12, no. 1, pp. 39–50, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. G. L. David, S. Yegnasubramanian, A. Kumar et al., “MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-aza-cytidine,” Cancer Biology & Therapy, vol. 3, no. 6, pp. 540–548, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. C. F. Higgins, “Multiple molecular mechanisms for multidrug resistance transporters,” Nature, vol. 446, no. 7137, pp. 749–757, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. D. B. Longley and P. G. Johnston, “Molecular mechanisms of drug resistance,” The Journal of Pathology, vol. 205, no. 2, pp. 275–292, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Labialle, L. Gayet, E. Marthinet, D. Rigal, and L. G. Baggetto, “Transcriptional regulation of the human MDR1 gene at the level of the inverted MED-1 promoter region,” Annals of the New York Academy of Sciences, vol. 973, pp. 468–471, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. M. M. Gottesman, T. Fojo, and S. E. Bates, “Multidrug resistance in cancer: role of ATP-dependent transporters,” Nature Reviews Cancer, vol. 2, no. 1, pp. 48–58, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Song, X. S. Liu, S. J. Rice et al., “Plk1 phosphorylation of Orc2 and Hbo1 contributes to gemcitabine resistance in pancreatic cancer,” Molecular Cancer Therapeutics, vol. 12, no. 1, pp. 58–68, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Strebhardt and A. Ullrich, “Targeting polo-like kinase 1 for cancer therapy,” Nature Reviews Cancer, vol. 6, no. 4, pp. 321–330, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Hikichi, K. Honda, K. Hikami et al., “TAK-960, a novel, orally available, selective inhibitor of polo-like kinase 1, shows broad-spectrum preclinical antitumor activity in multiple dosing regimens,” Molecular Cancer Therapeutics, vol. 11, no. 3, pp. 700–709, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. J. R. Jackson, D. R. Patrick, M. M. Dar, and P. S. Huang, “Targeted anti-mitotic therapies: can we improve on tubulin agents?” Nature Reviews Cancer, vol. 7, no. 2, pp. 107–117, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Herrera-Carrillo and B. Berkhout, “Gene therapy strategies to block HIV-1 replication by RNA interference,” in Gene Therapy for HIV and Chronic Infections, vol. 848 of Advances in Experimental Medicine and Biology, pp. 71–95, Springer, New York, NY, USA, 2015. View at Publisher · View at Google Scholar
  14. C. Lei, Y. Cui, L. Zheng, P. Kah-Hoe Chow, and C.-H. Wang, “Development of a gene/drug dual delivery system for brain tumor therapy: potent inhibition via RNA interference and synergistic effects,” Biomaterials, vol. 34, no. 30, pp. 7483–7494, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Han, Q. Wang, Z. Zhang, T. Gong, and X. Sun, “Cationic bovine serum albumin based self-assembled nanoparticles as siRNA delivery vector for treating lung metastatic cancer,” Small, vol. 10, no. 3, pp. 524–535, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. L. N. Borgheti-Cardoso, L. V. Depieri, H. Diniz et al., “Self-assembling gelling formulation based on a crystalline-phase liquid as a non-viral vector for siRNA delivery,” European Journal of Pharmaceutical Sciences, vol. 58, no. 1, pp. 72–82, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Petrelli, R. Carollo, M. Cargnelutti et al., “By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy,” Oncotarget, vol. 6, no. 4, pp. 2315–2330, 2015. View at Google Scholar · View at Scopus
  18. Z. Yang, B. Xiang, D. Dong, Z. Wang, J. Li, and X. Qi, “Dual receptor-specific peptides modified liposomes as VEGF siRNA vector for tumor-targeting therapy,” Current Gene Therapy, vol. 14, no. 4, pp. 289–299, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Acharya and R. A. Hill, “High efficacy gold-KDEL peptide-siRNA nanoconstruct-mediated transfection in C2C12 myoblasts and myotubes,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 10, no. 2, pp. 329–337, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Heinemann, M. Schomaker, S. Kalies et al., “Gold nanoparticle mediated laser transfection for efficient siRNA mediated gene knock down,” PLoS ONE, vol. 8, no. 3, Article ID e58604, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Tian, J. Sun, H. Yan et al., “A rapid and convenient method for detecting a broad spectrum of malignant cells from malignant pleuroperitoneal effusion of patients using a multifunctional NIR heptamethine dye,” Analyst, vol. 140, no. 3, pp. 750–755, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. O. S. Muddineti, B. Ghosh, and S. Biswas, “Current trends in using polymer coated gold nanoparticles for cancer therapy,” International Journal of Pharmaceutics, vol. 484, no. 1-2, pp. 252–267, 2015. View at Publisher · View at Google Scholar
  23. S. Wang, Z. Teng, P. Huang et al., “Reversibly extracellular pH controlled cellular uptake and photothermal therapy by pegylated mixed-charge gold nanostars,” Small, vol. 11, no. 15, pp. 1801–1810, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Nie, S. Wang, X. Wang et al., “In vivo volumetric photoacoustic molecular angiography and therapeutic monitoring with targeted plasmonic nanostars,” Small, vol. 10, no. 8, pp. 1585–1593, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Huang, L. Bao, C. Zhang et al., “Folic acid-conjugated silica-modified gold nanorods for X-ray/CT imaging-guided dual-mode radiation and photo-thermal therapy,” Biomaterials, vol. 32, no. 36, pp. 9796–9809, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Ke, X. Yue, J. Wang et al., “Gold nanoshelled liquid perfluorocarbon nanocapsules for combined dual modal ultrasound/ct imaging and photothermal therapy of cancer,” Small, vol. 10, no. 6, pp. 1220–1227, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Tian, S. Luo, H. Yan et al., “Gold nanostars functionalized with amine-terminated PEG for X-ray/CT imaging and photothermal therapy,” Journal of Materials Chemistry B, vol. 3, no. 21, pp. 4330–4337, 2015. View at Publisher · View at Google Scholar
  28. D. Kim, Y. Y. Jeong, and S. Jon, “A drug-loaded aptamer—gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer,” ACS Nano, vol. 4, no. 7, pp. 3689–3696, 2010. View at Publisher · View at Google Scholar · View at Scopus